SANJIV SUR to Interleukin-5
This is a "connection" page, showing publications SANJIV SUR has written about Interleukin-5.
Connection Strength
0.627
-
Interleukin-4/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthma. Curr Opin Allergy Clin Immunol. 2019 02; 19(1):30-37.
Score: 0.152
-
Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5. Curr Opin Allergy Clin Immunol. 2018 Feb; 18(1):26-31.
Score: 0.142
-
IgE and eosinophils as therapeutic targets in asthma. Curr Opin Allergy Clin Immunol. 2017 Feb; 17(1):42-49.
Score: 0.132
-
Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1. PLoS One. 2015; 10(5):e0126035.
Score: 0.118
-
Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation. J Immunol. 2002 Feb 15; 168(4):1978-83.
Score: 0.047
-
Treating insect bite hypersensitivity in horses by using active vaccination against IL-5. J Allergy Clin Immunol. 2018 10; 142(4):1060-1061.
Score: 0.037